To identify antitumor effect of CD and/or IFN-β genes, we performed cell viability assay with a co-culture of LNCaP prostate cancer cells and HB1.F3.CD or HB1.F3.CD.IFN-β cells. The gene discussed is IFNB1; the disease is prostate carcinoma.